Cardiovascular health, heart failure, atherosclerosis, and cardiac research
457 articles
EASIX — calculated from creatinine, LDH, and platelets — independently predicts mortality in over 3,200 coronary artery disease patients.
A transcription factor in endothelial cells declines with age and its loss drives fibrosis, hypertrophy, and diastolic dysfunction — but restoring it reverses damage.
A completed Montreal trial tested remote physical and cognitive training in 122 older adults with cardiovascular disease.
A completed University of Florida trial probes why aerobic exercise improves artery function in older men but yields inconsistent results in postmenopausal women.
Simon Hill ranks 8 popular supplements by human evidence for reversing atherosclerosis — one stands far above the rest.
A forensic autopsy study of 112 individuals found no correlation between omega-3 status and coronary artery stenosis — but the population's omega-3 index was dangerously low.
AHA, ACC, ESC, and WHF release a landmark 2026 consensus redefining heart failure staging and classification worldwide.
New review shows where fat is stored — not total body weight — determines atherogenic dyslipidemia and heart disease risk.
A comprehensive clinical overview of dyslipidemia — its causes, classification, target levels, and evidence-based prevention strategies.
A new AHA scientific statement exposes dangerous gaps in diagnosing and treating heart failure in pregnant and postpartum women.
Long-term follow-up shows cliramitug safely depletes cardiac amyloid with improving heart structure, function, and quality of life.
Real-world registry data shows 54% of coronary artery disease patients meet eligibility criteria for semaglutide based on SELECT and SOUL trial standards.
